Loading...
Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
Gastroenteropancreatic (GEP) neuroendocrine tumors (NETs) represent the most common subtype of NETs. The incidence of all NETs, and specifically GEP NETs, has risen exponentially over the last three decades. Only within the past several years have these tumors been appropriately classified, allowing...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8141991/ https://ncbi.nlm.nih.gov/pubmed/34093744 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211018047 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|